• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多巴胺受体激动剂对纹状体多巴胺转运体结合位点无作用。

Lack of dopamine receptor agonists effect on striatal dopamine transporter binding sites.

作者信息

Little K Y, Gorebig J, Carroll F I, Mapili J, Meador-Woodruff J H

机构信息

Department of Psychiatry, University of Michigan, Ann Arbor 48109, USA.

出版信息

Brain Res. 1996 Dec 2;742(1-2):313-6. doi: 10.1016/s0006-8993(96)01033-5.

DOI:10.1016/s0006-8993(96)01033-5
PMID:9117410
Abstract

Depending on experimental conditions, chronic cocaine exposure can induce an increase in binding to the dopamine transporter (DAT). One possible mechanism for the cocaine-induced-upregulation in DAT binding sites is through stimulation of presynaptic D2 receptors by excess synaptic dopamine. To test this hypothesis, the present experiment examined in rats the effect of chronic quinpirole and apomorphine treatments on striatal DAT binding sites. Rats were chronically injected subcutaneously with either: quinpirole, 0.7 mg/kg body weight, apomorphine, 2.0 mg/kg body weight, or vehicle. Striatal DAT binding was then examined autoradiographically using the DAT-selective cocaine congeners [125I]RTI-121 and [3H]WIN 35428. Analysis of the results indicated that quinpirole and apomorphine administration did not alter DAT cocaine binding sites.

摘要

根据实验条件,长期接触可卡因可导致多巴胺转运体(DAT)结合增加。可卡因诱导DAT结合位点上调的一种可能机制是通过过量突触多巴胺刺激突触前D2受体。为了验证这一假设,本实验研究了大鼠长期使用喹吡罗和阿扑吗啡治疗对纹状体DAT结合位点的影响。大鼠被皮下长期注射以下药物之一:喹吡罗,0.7mg/kg体重;阿扑吗啡,2.0mg/kg体重;或溶剂。然后使用DAT选择性可卡因类似物[125I]RTI-121和[3H]WIN 35428通过放射自显影法检测纹状体DAT结合情况。结果分析表明,给予喹吡罗和阿扑吗啡不会改变DAT可卡因结合位点。

相似文献

1
Lack of dopamine receptor agonists effect on striatal dopamine transporter binding sites.多巴胺受体激动剂对纹状体多巴胺转运体结合位点无作用。
Brain Res. 1996 Dec 2;742(1-2):313-6. doi: 10.1016/s0006-8993(96)01033-5.
2
Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride].纹状体内注射不可逆抑制剂RTI-76[3β-(3-对氯苯基)托烷-2β-羧酸对异硫氰酸苯乙酯盐酸盐]后多巴胺转运体结合及功能的恢复
J Pharmacol Exp Ther. 1996 Oct;279(1):200-6.
3
Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.多巴胺D1和D2受体影响大鼠体内多巴胺转运体的合成与降解。
J Pharmacol Exp Ther. 2001 Jul;298(1):129-40.
4
Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem study.可卡因使用者大脑中的多巴胺转运体信使核糖核酸及结合位点:一项尸检研究
Arch Gen Psychiatry. 1998 Sep;55(9):793-9. doi: 10.1001/archpsyc.55.9.793.
5
Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transporters.多巴胺能药物对[3H]WIN 35,428在体内与中枢多巴胺转运体结合的影响。
Synapse. 1996 Jun;23(2):61-9. doi: 10.1002/(SICI)1098-2396(199606)23:2<61::AID-SYN1>3.0.CO;2-E.
6
Regulation of rat dopamine transporter mRNA and protein by chronic cocaine administration.长期给予可卡因对大鼠多巴胺转运体mRNA和蛋白的调节作用。
J Neurochem. 1999 Nov;73(5):1982-9.
7
Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine.蛋白激酶A活性可能在动力学上上调多巴胺的纹状体转运体。
J Neurosci. 1998 Dec 15;18(24):10304-9. doi: 10.1523/JNEUROSCI.18-24-10304.1998.
8
Characterization and localization of [125I]RTI-121 binding sites in human striatum and medial temporal lobe.[125I]RTI-121结合位点在人纹状体和内侧颞叶中的表征与定位
J Pharmacol Exp Ther. 1995 Sep;274(3):1473-83.
9
Cocaine use increases [3H]WIN 35428 binding sites in human striatum.使用可卡因会增加人体纹状体中[3H]WIN 35428结合位点。
Brain Res. 1993 Nov 19;628(1-2):17-25. doi: 10.1016/0006-8993(93)90932-d.
10
Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter.多巴胺转运体过表达小鼠中D2介导的信号传导活性降低以及D1和D2多巴胺受体的跨突触上调。
Cell Signal. 2009 Jan;21(1):87-94. doi: 10.1016/j.cellsig.2008.09.011. Epub 2008 Sep 30.

引用本文的文献

1
Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor.低剂量普拉克索在帕金森病的MPTP小鼠模型中具有神经保护作用,并通过D3受体下调多巴胺转运体。
BMC Biol. 2004 Oct 11;2:22. doi: 10.1186/1741-7007-2-22.
2
[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease.[(123)I]β-羧化酶转运体单光子发射计算机断层扫描是监测早期帕金森病多巴胺能神经元变性的一种有用方法。
J Neurol Neurosurg Psychiatry. 2003 Mar;74(3):294-8. doi: 10.1136/jnnp.74.3.294.